Meprobamate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Dr.reddy's Laboratories Limited. The primary component is Meprobamate.
Product ID | 55111-641_4995ef74-5377-6fdf-5a0a-0ea1925c35fb |
NDC | 55111-641 |
Product Type | Human Prescription Drug |
Proprietary Name | Meprobamate |
Generic Name | Meprobamate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2008-01-03 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA040797 |
Labeler Name | Dr.Reddy's Laboratories Limited |
Substance Name | MEPROBAMATE |
Active Ingredient Strength | 400 mg/1 |
DEA Schedule | CIV |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2008-01-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA040797 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-01-03 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA040797 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-01-03 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
MEPROBAMATE | 400 mg/1 |
SPL SET ID: | d6fa7f20-5125-ff79-4e8d-00542a13472a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
46708-019 | MEPROBAMATE | MEPROBAMATE |
46708-020 | MEPROBAMATE | MEPROBAMATE |
51672-4147 | Meprobamate | Meprobamate |
51672-4148 | Meprobamate | Meprobamate |
52549-4147 | Meprobamate | Meprobamate |
52549-4148 | Meprobamate | Meprobamate |
55111-640 | Meprobamate | Meprobamate |
55111-641 | Meprobamate | Meprobamate |
62332-019 | Meprobamate | Meprobamate |
62332-020 | Meprobamate | Meprobamate |
69097-974 | Meprobamate | Meprobamate |
69097-975 | Meprobamate | Meprobamate |